Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ancilla Domini International Researchers (ADIR) is a premier full-service Contract Research Organization (CRO) headquartered in the Philippines. Established in 2004, the company provides comprehensive clinical research services, including clinical trial management, regulatory affairs, site monitoring, and pharmacovigilance. ADIR specializes in Phase I through Phase IV clinical trials across a broad spectrum of therapeutic areas such as oncology, infectious diseases, and cardiovascular medicine. The organization serves as a strategic partner for global pharmaceutical and biotechnology firms, facilitating efficient trial execution and regulatory compliance within the Philippine healthcare ecosystem. By leveraging deep local expertise and established relationships with investigators and regulatory bodies, ADIR ensures high-quality data and adherence to international ICH-GCP standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ancilla Domini International Researchers.